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ABSTRACT
Purpose To study composition and heterogeneity of insoluble
subvisible particles in Mab formulations resulting from degradation
of polysorbate 20 and to develop a better understanding of the
mechanisms of polysorbate degradation leading to particle
formation.
Methods In this study, we exploit the potential of Raman mi-
croscopy for chemical identification of particles in monoclonal
antibody formulations. Through a combination of experiments
and density functional theory (DFT) calculations, we identified
unique spectral marker bands for insoluble degradation products
of polysorbate 20. We first applied our methodology to identify
particles in model systems containing complex mixtures of fatty
acids and then to subvisible particles in antibody formulations
stored at 5°C for several years.
Results Most of the subvisible particles identified were com-
prised of mixtures of fatty acids with no observable signal from
fatty acid esters consistent with hydrolysis being the predominant
degradation mechanism leading to particulate formation under
these storage conditions.
Conclusions Our methodology is generally applicable for identifi-
cation of particles in antibody formulations and, in particular, has the
potential to give detailed information about particle heterogeneity
and insight into mechanistic aspects of particle formation.
KEY WORDS degradation . fatty acid . particle identification .
polysorbate 20 . Raman spectroscopy
ABBREVIATIONS
DFT Density functional theory
ELSD Evaporative light scattering detector
HPLC High performance liquid chromatography
Mab Monoclonal antibody
INTRODUCTION
Control of particles in biopharmaceutical formulations is of
particular importance when developing the manufacturing
process, assessing product quality, and addressing safety con-
cerns (1). There has been a significant amount of effort spent
on the quantification of subvisible particles in protein thera-
peutics as regulatory health authorities expect biopharmaceu-
tical companies to characterize the occurrence of particles
>10 μm and >25 μm as outlined in the pharmacopeias, e.g.,
USP <787>and USP <788>(2,3). Recently, concerns have
been raised that proteinaceous subvisible particles may trigger
immunogenic responses, but the roles of particle chemical
composition and structure in generating an immune response
are under debate as these attributes are particularly difficult to
characterize (2,4). It is noted that all biotherapeutics contain
subvisible particles, most of which are not harmful and well
within the USP specification (4). For products containing high
or varied particle counts, identification of particles is key in
assessing potential mechanism and impact on product quality.
Subvisible particles in protein formulations mostly show a
continuous size distribution that can range from a fewmicrons
to hundreds of microns (4,5). Particles with a size smaller than
one micron are considered submicron particles and are espe-
cially difficult to count and characterize. There are only few
techniques commercially available to study submicron
particles such as nanoparticle tracking (NanoSight®) or
microchannel resonator (Archimedes®), but these possess lim-
ited accessible particle size and concentration ranges as well as
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other technical limitations (6,7). Promising results in
distinguishing proteinaceous particles from silicone oil have
been obtained using the microchannel resonator, but in gen-
eral, routine characterization of submicron particles is not yet
possible (6). Characterization of subvisible particles is mostly
performed using optical techniques, which rely on good opti-
cal contrast between the particles and the solution. Over the
last few years, flowmicroscopy techniques such as Micro-Flow
Imaging® or FlowCAM® were introduced and are being
evaluated to count subvisible particles >1 μm and provide
morphology data of particles >5 μm (note that the lower size
limit depends on the optics and flow cells utilized in addition
to the optical contrast between the particles and the solution)
(8). Particle identification based on morphology using flow
microscopy allows for discrimination of air bubbles and sili-
cone oil from proteinaceous and foreign particles (8,9). Flow
imaging techniques, however, lack the ability to provide infor-
mation about the exact chemical identity of the investigated
particles and their heterogeneity. Techniques that give infor-
mation about the chemical composition of subvisible particles
are limited to electron microscopy (SEM-EDX for inorganic
compounds) and vibrational spectroscopy (10). Two types of
vibrational spectroscopy are frequently employed for particle
identification: Fourier transform infrared spectroscopy (FTIR)
and dispersive Raman spectroscopy (10,11). For routine anal-
ysis, FTIR spectroscopy is usually employed because of its
versatility and easier handling. The drawback of FTIR spec-
troscopy is its inherent sensitivity to water both in the atmo-
sphere as well as in aqueous solution resulting in interference
and low-quality data. This is particular true for smaller size
particles where signal-to-noise is very low. The lower limit of
detectable particle size using IR reflection is in the 10–20 μm
range and not sufficient to cover the typical particle size range
for our products (4). On the other hand, dispersive Raman
spectroscopy is advantageous for studying biological systems
because water shows only minor Raman activity and the use
of lasers enables detection of smaller size particles (possibly as
low as 0.5 μm for strong scattering molecules such as metal
complexes) (10). However, sample acquisition is more de-
manding and care must be taken to avoid laser-induced pho-
to-damage of the sample. In addition, multi-laser configura-
tions are necessary to optimize Raman scattering and mini-
mize background fluorescence.
The major types of particles occurring in pharmaceutical
formulations are usually classified as extrinsic, intrinsic and
inherent particles (4). Intrinsic particles are those that are un-
intentionally introduced during the manufacturing process or
during non-sterile sample handling. This category usually in-
cludes glass, metal pieces and fibers such as cellulose. The
difference between intrinsic and extrinsic particles is that the
latter ones are not process-related. Inherent particles are
product-related and comprised of degradation products of
excipients and proteins in formulations.
Most work focuses on characterization of extrinsic particles.
In recent years, product-related particles have gained wide
attention due to the potential concerns about immunogenicity
of protein particles (2). Within this frame, recent reviews have
highlighted the potential impact of excipient degradation, e.g.,
polysorbate 20 degradation, on protein stability (12,13).
Polysorbate 20 is a commonly used surfactant in protein for-
mulations and is typically used to stabilize protein pharmaceu-
ticals against various stresses such as agitation-induced aggre-
gation or surface adsorption (13). It is a chemically diverse
mixture containing mainly sorbitan polyoxyethylene fatty acid
esters. The composition of the fatty acid side chains varies from
lot to lot with lauric acid (40–60%), myristic acid (14–25%),
palmitic acid (7–15%) and capric acid (≤10%) being the main
species. It is known that polysorbates can degrade via two
known pathways: hydrolysis and autooxidation (12,13).
Hydrolysis creates fatty acids, which are prone to form insolu-
ble particles (12,13). Autooxidation is based on a radical mech-
anism and hence leads to a variety of degradation products,
e.g., peroxides or aldehydes, all of which might affect protein
stability. In addition, some of the fatty acid esters,
which also result from autooxidation, are insoluble
(13). A decrease in polysorbate 20 levels during storage
is a potential concern for protein stability due to de-
creased protection against interfacial stress and potential
interaction of degradation products with active anti-
body, which may lead to proteinaceous particles.
Autooxidation is significantly accelerated when formula-
tions are stored at high Bstress^ temperatures while hy-
drolysis has been implicated in mildly acidic conditions
even at relatively low temperatures (13). However, the
factors that influence each degradation pathway in pro-
tein formulations are still under debate and there is yet
no routine method to identify these types of particles
(12,13). Further, characterization of fatty acids and its
derivatives is particularly challenging due to the limited
stability of these particles in complex mixtures. They
have low melting points and are readily resolubilized
at ambient temperature. Hence, sample preparation
and investigation require stabilizing conditions such as
low temperature. Previous studies employed FTIR spec-
troscopy for particle identification but spectra in the
fingerprint region are usually cluttered and do not allow
for individual identification of highly similar com-
pounds, in particular in complex mixtures (14).
In the current study, we exploit the potential of dispersive
Raman spectroscopy at cryogenic temperatures for the iden-
tification of subvisible labile particles in biopharmaceutical
formulations resulting from degradation of polysorbate 20.
Particles resulting from degraded polysorbate 20 after long-
term storage of antibody formulations beyond shelf-life were
composed of mixtures of fatty acids consistent with a hydro-
lytic mechanism leading to particle formation. We developed
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Purified dry capric acid, lauric acid, myristic acid, palmitic
acid and ethylene glycol monolaurate with purity >98% were
purchased from Supelco (Bellefonte, USA). Polysorbate 20
was purchased from Croda International PLC (Snaith, UK).
Hydrated fatty acid particles were prepared by stirring dry
fatty acids as received in water for 30 min. The particles were
filtered through a gold-coated polycarbonate filter (filtr.AID
with 5 μm pore size from rap.ID, Germany) and washed with
2 mL water.
Enzymes for digestion were obtained from Sigma-Aldrich
(St. Louis, Missouri). Hydrolysis was performed by digesting
0.2 mg/mL polysorbate 20 in 20 mM sodium acetate at
pH 5.5 with 30 ppm rabbit liver esterase or 30 ppm pancreatic
lipase at 40°C for 12 h. The reaction was stopped by storing
samples at 5° where the reaction rate was reduced to essen-
tially zero.
Monoclonal antibody was produced by Genentech Inc.
(South San Francisco, California). MAb1 and Mab2 were
formulated at 30–50 mg/mL with typical biological buffers
containing sucrose and 0.02% polysorbate 20 (w/v).
Mab1 was stored at 5°C for 4 years while Mab2 was
stored at 5°C for 6 years. This is well beyond the typical
shelf-life of a product stored at 2–8°C, which is usually 2–
3 years. Both samples showed significant polysorbate 20 deg-
radation (see Results and discussion).
HPLC to Quantify Polysorbate 20 Degradation
High-performance liquid chromatography was performed on
an Agilent Infinity 1260 setup equipped with a temperature-
controlled autosampler, column oven, binary gradient pump
and evaporative light scattering detector (ELSD, 380-LS,
Varian). The ELSD was used with a gas flow rate of 1 stan-
dard liter per minute (SLM), nebulizer temperature of 45°C
and evaporation temperature of 100°C. The column temper-
ature was set to 30°C. A gradient using two mobile phases as
described earlier was used (15). In brief, mobile phase A
contained 2% formic acid in water and mobile phase B 2%
formic acid in isopropanol. Intact polysorbate 20 was quanti-
fied by loading 20 μL of sample onto a Waters Oasis MAX
cartridge column (20 mm×2.1 mm, particle size 30 μm).
The flow rate was set to 1 mL/min starting with 90%
of mobile phase A. After 1 min, mobile phase B was
increased to 20%. After 3.4 min, mobile phase B was
increased to 80% and after 3.5 min, to 100%, where it was
kept for 0.9 min. After 4.7 min, mobile phase B was set to the
initial condition of 10%. Intact polysorbate 20 elutes as a
single peak at approximately 4.6 min.
Raman Spectroscopy
Particles from aged antibody samples were isolated by filtering
0.5–1 mL cold sample through a gold-coated polycarbonate
filter (filtr.AID with 5 μm pore size from rap.ID, Germany)
and washing with >2 mL ice-cold water. Filters were either
immediately dried in a desiccator over phosphorous pentox-
ide for 2 h to remove residual water or directly transferred to a
cold cryo-cell without drying (see below). Vibrational
spectra were collected on a Morphologi G3-ID disper-
sive Raman microscope equipped with a 785 nm diode
laser (Malvern Instruments Ltd, UK). The setup is com-
prised of a RamanRxn1 spectrometer (Kaiser Optical
Systems, Inc., USA) and a CFI 60 brightfield/darkfield
microscope (Nikon Corporation, Japan). The light was
focused through a 50X objective to a spot size of 3 μm
and the resulting laser power at the sample was either
4 mW in low power mode or 16 mW in high power
mode as controlled with a power meter. Scattered light
was detected using a high-performance CCD camera.
Raman spectra were collected in the spectral region
between 150 and 1850 cm−1 with a spectral resolution
of 4 cm−1. Exposure time varied depending on the na-
ture of the particles and was usually between 60 s and
5 min to minimize photodamage.
Low temperature experiments were carried out using a
FDCS196 cryostage (Linkam Scientific Instruments Ltd,
UK) equipped with a quartz window in which the gold-
coated filter containing particles was enclosed and cooled to
a temperature between T=−40°C to T=−120°C by means
of nitrogen gas.
Theory
Quantum chemical calculations were performed using
Gaussian 09 (16). Geometries of the molecules were optimized
in the gas-phase using the B3LYP functional and 6-311++
G(d,p) basis sets (17,18). Vibrational frequencies were calcu-
lated using the harmonic approximation and scaled using a
wavenumber linear scaling procedure according to Yoshida,
et al., with
eνobs ¼ 1:0087− 0:0000163 ⋅eνcalcð Þ ⋅eνcalc
whereeνobs andeνcalc are the observed and the calculated Raman
shifts, respectively (19).
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Gaussian output consists of Raman activities, Ak,
rather than Raman intensities Ik. To obtain Raman inten-
sities, the Raman activities were converted using a frequency
dependent factor
I k ¼ ω0 −ωkð Þ
4
ωk 1 − exp −
hωk
kBT
   ⋅ Ak
where h is Planck’s constant, kB the Boltzmann constant, ωk
the vibrational frequency of mode k, and ω0 the frequency of
the incident laser light (785 nm laser exCitation) (20). The
temperature, T, was chosen to be 293 K.
RESULTS AND DISCUSSION
Degradation of protein as well as excipients in biopharmaceu-
tical formulations can lead to formation of insoluble species
and the observation of particles. Understanding mechanisms
of degradation, in particular of excipients used to stabilize
antibody against various stress conditions, is crucial for prod-
uct quality and protein stability. In this study we focus on
insoluble degradation products of polysorbate 20, a surfactant
commonly added to formulations to protect antibody against
interfacial stress conditions. Polysorbate 20 can form different
insoluble degradation products such as fatty acids or fatty acid
esters, which are indicative for the mechanism of degradation.
To distinguish highly similar molecules using vibrational spec-
troscopy it is important to identify unique spectral marker
bands for each compound first using a combination of exper-
iments and theory. Since the microenvironment of each mol-
ecule in the particles can be different than the local structure
in the reference compound it is crucial to identify any changes
in vibrational spectra, e.g., changes in hydrogen bonding.
In this study, we present an analytical approach to eluci-
date the chemical composition of visible particles, as well as
subvisible particles, by direct spectroscopic analysis of particles
captured on filters. This approach can be used to elucidate the
mechanism of degradation of polysorbate 20 in model systems
and two antibody formulations and is generally applicable to
similar systems. First, a spectral library of known degradation
products was created. Then, unique spectral marker bands for
some of the potential degradation products were identified by
analysis of pure reference compounds. Control experiments
were performed to evaluate changes in vibrational spectra of
the dry reference compounds upon transition into the hydrat-
ed state in which particles can be typically found. This ensures
that bands associated with different hydration states are not
mistaken for unique signature bands for a particular degrada-
tion product. In, addition, comparison of experimental data
with calculated spectra obtained from quantum-chemical
calculations using density functional theory (DFT), allowed
confirmation of reliable marker bands. The calculations were
able to distinguish similar compounds and to rule out the
presence of other polysorbate 20 degradation products in
the experimental data.
We then collected Raman spectra on particles generated in
two model systems in which polysorbate 20 was digested with
different enzymes that both hydrolyze the ester bonds between
the sorbitan moiety and the fatty acid side chains resulting in
insoluble particles of complex composition, i.e., mixtures of
fatty acids. Finally, we characterized subvisible particles from
two different biopharmaceutical formulations, which were
stored at low temperature over an extended period of several
years beyond typical shelf-life and had shown a significant loss
of intact polysorbate.
Raman Spectra of Dry Fatty Acids
In order to create a spectral library that includes reference
spectra, Raman spectra of purified dry fatty acids were col-
lected. The fatty acid particles were placed on a clean gold-
coated polycarbonate filter. Raman scattering scales with the
frequency, ν, of the incident laser beam as~ν4. To achieve
maximal scattering, a laser excitation with 532 nm was used,
but this resulted in significant background fluorescence (in
particular with particles from protein formulations, see be-
low). Therefore, we proceeded with using 785 nm excitation
where only minimal fluorescence was detected.
Raman spectra of the dry fatty acids capric acid, lauric
acid, myristic acid and palmitic acid were obtained using
low laser power and are shown in Fig. 1. Characteristic for
all fatty acids is the presence of two intense bands between
1050 and 1150 cm−1 arising from ν(C-C) stretch vibrations,
one band at 1299 cm−1 arising from γ(CH2) twisting and a
group of bands between 1400 and 1500 cm−1 caused by
γ(CH2) wagging, γ(CH2) scissoring as well as δ(CH2) and
δ(CH3) deformation vibrations (21). Typically carbonyl
stretch frequencies of aliphatic compounds are found above
1700 cm−1. The carbonyl stretch frequency ν(C=O) of the
fatty acids is red-shifted to 1640 cm−1 and shows only moder-
ate Raman intensity indicating a local environment in which
the carbonyl is hydrogen bonded (22). This peak is split into
two peaks for lauric, myristic and palmitic acid suggesting
heterogeneity of hydrogen bonding in the particle structure.
It can be seen that the spectra of the four fatty acids are
highly similar. However, three characteristic marker bands
can be identified helping to distinguish them. The first one is
a ν(C-C) stretch vibration withmoderate Raman intensity that
is shifting consecutively from 1075 cm−1 in capric acid to
1085 cm−1 (lauric acid), 1093 cm−1 (myristic acid) and
1100 cm−1 in palmitic acid. The second notable difference is
that the doublet originating from γ(CH2) rocking modes at
894 and 910 cm−1 is changing relative intensities with the
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band at 910 cm−1 decreasing in intensity when increasing the
chain length of the fatty acid. The most prominent marker
band is a low frequency vibration at 466 cm−1 in lauric acid
which is red-shifted to 415 cm−1 in myristic acid and to
376 cm−1 in palmitic acid. This band is absent in capric acid.
There are some minor differences in the spectral region be-
tween 1400 and 1500 cm−1 due to changes in the CH bending
modes between the different fatty acids. However, this spectral
region is very cluttered and does not allow for identification of
fatty acids in complex mixtures. Therefore we only focus on
the three marker bands described above.
Effect of Water on the Raman Spectra
Our reference database contains spectra of dry fatty acids.
Dry fatty acids typically exist in three major forms designated
as α-, β- and γ-form, which mostly differ in the orientation of
the side chains of the aligned fatty acids in their structure as
well as slight changes in the hydrogen bonding of the acid
headgroups or they can be amorphous (23,24). Most protein
formulations are in aqueous solution and fatty acid particles
most likely do not retain their initial dry state. In addition,
particles resulting from mixtures of fatty acids might have
partial disorder in their structure and different hydrogen
bonding patterns. Therefore, we evaluated the effect of water
on the Raman spectra. Hydrated fatty acid particles were
filtered through a gold-coated polycarbonate filter and
washed with water. Several effects in the spectra are observed
including the disappearance of the band corresponding to the
low frequency vibration between 376 and 466 cm−1 (Fig. S1).
Another effect observed is that the relative intensities of the
γ(CH2) rocking modes change with the band at 910 cm−1
increasing in intensity after the water wash. The last notable
difference is a blue-shift of a γ(CH2) vibration at 1425 cm−1
resulting in an intense band around 1436 cm−1. It is worth
noting that the characteristic marker band due to the ν(C-C)
stretch vibration between 1075 and 1100 cm−1 does not
change at all and can still be used to distinguish different
amorphous fatty acids. The fact, that there are no changes
in the carbonyl ν(C=O) stretch frequency, which is a highly
localized mode, implies that the hydrogen bonding to the acid
group in the particle structure is similar as in the reference
compound. Since only some vibrations in the fingerprint re-
gion are affected by hydration this indicates that there are
small structural changes of the fatty acid side chain orienta-
tions in the particle. Therefore, care must be taken when
comparing experimental vibrational spectra with reference
libraries because the microenvironment of the investigated
molecule can change key features due to specific interactions
or reorientation in the particle structure. Nevertheless, there
are still features in the spectra that are not affected by hydra-
tion and can be used for identification of similar fatty acids
such as the characteristic ν(C-C) stretch vibration between
1075 and 1100 cm−1.
Raman Spectroscopy at Low Temperatures
Melting points of the fatty acids are between 63°C for palmitic
acid and 32°C for capric acid (25). In mixtures of fatty acids,
the eutectic point will be lower than the melting point of the
component with the lowest melting point. We found that
Raman experiments carried out at room temperature resulted
in melting of the particles due to the heat created by the laser.
Keeping the sample at low temperature increases stability of
labile particles and allows for higher power laser illumination
to obtain better signal to noise. Therefore, the possibility of
low temperature Raman experiments to provide stabilizing
conditions was evaluated. In addition, lower temperature usu-
ally results in narrower spectral linewidths and hence im-
proved resolution. However, at low temperatures reorienta-
tion of molecules within the particle might occur, especially
due to changes in hydrogen bond lengths and angles, causing
bandshifts due to these specific changes. Control experiments
were performed to evaluate if the identified marker bands are
affected by temperature changes. The focus will be on the ν(C-
Fig. 1 Experimental Raman spectra of dry fatty acids (a) capric acid (b) lauric
acid (c) myristic acid and (d) palmitic acid. Experimental conditions: 4 mW
laser power, T=298 K, 60 s accumulation time.
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C) stretch vibration between 1075 and 1100 cm−1 because this
marker band was not affected by changes in hydration and/or
crystal structure in contrast to the γ(CH2) rocking and low
frequency vibrations between 376 and 466 cm−1 (Fig. S1).
No significant bandshifts were observed when changing the
temperature over the entire range from −40°C to −120°C
(<1 cm−1 total change).
As mentioned previously, decreased linewidth allows better
resolution to more readily assess mixtures of highly similar
fatty acids. The linewidth of the ν(C-C) stretch marker band
decreases from 10 cm−1 at 20°C to 8 cm−1 at −40°C for all
fatty acids (Fig. S3). No further improvement is achieved by
decreasing the temperature down to −120°C. For this reason,
all low temperature experiments were performed at −40°C.
Calculated Raman Spectra of Fatty Acids
To further distinguish similar polysorbate 20 degradation
products, density functional theory (DFT) was used to calcu-
late the vibrational spectra associated with various fatty acids
that could potentially arise from polysorbate 20 degradation.
Previous DFT studies have demonstrated that reasonable
agreement between in vacuo calculated and experimentally ob-
served vibrational frequencies can be obtained using harmon-
ic approximation for a wide range of compounds (26,27). In
this case, vibrational frequencies are usually overestimated
and have to be scaled using empirical factors for certain com-
binations of functional and basis set. We have chosen a wave-
length linear scaling procedure described by Yoshida et al. for
correction of anharmonicity, which has been previously used
for fatty acids (19,23).
Non-linear molecules have 3N-6 vibrational degrees of
freedom, where N depicts the number of atoms. Capric acid
has 32 atoms resulting in 90 normal modes and palmitic acid
50 atoms resulting in 144 normal modes. Hence, the vibra-
tional spectra are complex. A comprehensive normal mode
analysis for γ–form of oleic acid using DFT has been done in
previous work and our analysis is based on these results (23).
The calculated Raman spectra are shown in Fig. 2. In
general the calculations are able to reproduce experimental
vibrational frequencies and intensities reasonably well when
compared to experimental spectra shown in Fig. 1 especially
in the spectral region above 800 cm−1. Vibrational frequen-
cies for δ(CH2) rocking modes, ν(C-C) stretch modes and
δ(CH2) twisting mode are all within ±20 cm−1 compared to
experimental values (see Table I). The biggest discrepancy can
be seen for the carbonyl stretch ν(C=O), which is blue-shifted
to 1774 cm−1 in the calculated spectra. The fact that these
samples consist of solid-state particles on filters contributes
significantly to the sharpness of the experimental spectra, in
which band broadening due to solution dynamics is not ob-
served. Further, band shifts are negligible due to the hydro-
phobic nature of fatty acids which create negligible electric
field contributions. The discrepancy in the carbonyl stretch
frequency is attributed to the fact that specific interactions
such as hydrogen bonding are not included in the gas-phase
calculations.
Comparison of the calculated spectra of all four fatty acids
shows that they are very similar (as are the experimental spec-
tra). The calculations are able to predict the presence of the
same unique marker bands that were found in the experimen-
tal spectra. The ν(C-C) stretch mode that is shifting upon
chain extension from 1075 cm−1 in capric acid to
1100 cm−1 in palmitic acid is predicted to be shifting from
1070 to 1096 cm−1. The same is true for the low-frequency
vibration at 466 cm−1 in lauric acid that is red-shifted to
376 cm−1 in palmitic acid where calculations show this band
red-shifting from 459 to 365 cm−1. Calculations indicate the
presence of this band in capric acid to be at 486 cm−1 with low
Raman intensity. This might explain the lack of this band in
the experimental spectrum of capric acid because its predicted
Raman activity is very low.
In conclusion, DFT calculations are able to reproduce vi-
brational frequencies reasonably well. However, the ability of
the calculations to reproduce the Raman intensities at each
Fig. 2 Calculated Raman spectra of fatty acids using DFT. Spectra have been
scaled using a wavenumber linear scaling procedure according to Yoshida et al.
(19) (a) capric acid (b) lauric acid (c) myristic acid and (d) palmitic acid.
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frequency was challenging as seen for the δ(CH2) rocking
modes. Raman intensities are calculated from the derivative
of the molecular polarizability, and it is known that reliable
intensities depend mostly on the size and quality of the basis
set (20). The use of a large basis set enabled relatively accurate
reproduction of the overall relative intensities in the spectra,
but not the subtle changes in intensities seen for the δ(CH2)
rocking modes. In general, DFT calculations can be used to
predict the presence of specific marker bands and can aid in
their assignment in experimental spectra. They are particular-
ly useful to distinguish highly similar molecules such as fatty
acids or fatty acid esters and can support mechanistic
interpretations.
Raman Spectra of Common Particles Found in Protein
Formulations
This section describes the general advantage of Raman spec-
troscopy to distinguish between intrinsic, extrinsic as well as
inherent particles. Most particles have distinct spectral fea-
tures allowing for unambiguous identification (see below).
Figure 3 shows Raman spectra of particles, which are likely
to be found in antibody formulations. For comparison, trace
(a) contains the spectrum of dry lauric acid, which is a degra-
dation product of polysorbate 20 resulting from hydrolysis of
the side chain. The spectral features have already been
discussed in the previous section. Trace (b) shows the
Raman spectrum of ethylene glycol monolaurate, which is
one of the expected degradation products of polysorbate 20
caused by oxidation. Qualitatively, this spectrum is very sim-
ilar to lauric acid. However, subtle differences make it possible
to differentiate between both of them. The ν(C=O) stretch
vibration is blue-shifted to 1740 cm−1 and has a small
linewidth of 10 cm−1 indicating that the carbonyl group is
not hydrogen bonding in the crystal structure in ethylene gly-
col monolaurate. The δ(CH2) rocking vibrations at 893 and
908 cm−1 are merged together into one broadened band at
890 cm−1. The most prominent differences are changes
in these δ(CH2) rocking modes, which are red-shifted to
890 and 885 cm−1, and the absence of the characteristic
low-frequency vibration in ethylene glycol monolaurate
(466 cm−1 in lauric acid). Another unique feature of ethylene
Fig. 3 Raman spectra of common particulates and compounds found in
biopharmaceutical formulations (a) lauric acid (b) ethylene glycol monolaurate
(c) mechanically stressed antibody (d) silicone oil (e) cellulose and (f )
polypropylene. Experimental conditions: 4 mW laser power, T=298 K,
60 s accumulation time.
Table I Summary of Experimental and Calculated Vibrational Frequencies for the Specific Marker Bands and the Strong Bands in the Raman Spectra
Capric acid Lauric acid Myristic acid Palmitic acid
Exp. Calc. Exp. Calc. Exp. Calc. Exp. Calc.
Low-frequency vibration 488 486 466 459 415 407 376 365
δ(CH2) rocking 893 872 893 872 893 872 893 872
δ(CH2) rocking 908 891 908 891 908 891 908 891
ν(C-C) stretch 1065 1057 1064 1057 1064 1057 1064 1057
ν(C-C) stretch 1075 1070 1085 1080 1093 1089 1100 1096
ν(C-C) stretch 1126 1137 1127 1137 1129 1137 1129 1137
δ(CH2) twisting 1299 1311 1298 1309 1297 1308 1296 1308
ν(C=O) stretcha 1640 1774 1633 (1657) 1774 1630 (1649) 1774 1630 (1646) 1774
a The large discrepancy is due to the fact that the carbonyl group is not hydrogen bonded in the gas-phase calculations
Identification of Subvisible Particles in Formulations 2883
glycol monolaurate is the presence of a medium intensity band
at 1158 cm−1, which can be attributed to a ν(C-C) stretch
vibration. For comparison, the Raman spectrum of ethylene
glycol monolaurate was calculated using DFT as well (Fig. S2).
The most prominent differences to lauric acid are captured by
the calculations as well, i.e., changes in the rocking modes as
well as the disappearance of the low-frequency vibration.
There is very good agreement between the experimental
and calculated carbonyl stretch vibration ν(C=O) further cor-
roborating the experimental finding that the carbonyl group
of ethylene glycol monolaurate is not hydrogen bonded in the
crystal structure.
Under various stress conditions, protein aggregates often
times can be found in formulations. Trace (c) shows the spec-
trum of a protein particle generated by stressing a frozen for-
mulation containing an IgG1 therapeutic antibody using me-
chanical stress and thawing at room temperature. Even
though antibodies have a lot of vibrational degrees of free-
dom, they have unique marker bands mostly arising from
backbone and aromatic amino acid vibrations thus enabling
unambiguous identification using Raman spectroscopy (28).
All antibodies contain phenylalanine residues in the Fab and
Fc fragments. Phenylalanine has a sharp band around
1000 cm−1 originating from a breathing mode of its aromatic
ring. This mode is independent of its microenvironment and
can be used for normalization of spectra of the same antibody
(28). Around 1650 cm−1 a broad band arising mainly from
ν(C=O) backbone vibrations can be found (amide I) (28).
Another characteristic backbone mode arises from out-of-
phase combination of δ(N-H) bending and ν(C-N) stretching
vibrations around 1550 cm−1 (amide II).
A very common compound found in protein formulations
is silicone oil used for lubrication of stoppers and injection
devices such as syringes, cartridges and plungers. The
Raman spectrum of silicone oil shows several strong low-
frequency modes at 490 cm−1 and a doublet at 689 cm−1/
710 cm−1. The band at 490 cm−1 arises from ν(Si-O-Si)
stretch vibrations and the doublet at 689 cm−1/710 cm−1
from symmetric δ(Si-CH3) rocking vibrations (29).
Foreign particles can be introduced during manufacturing
of the drug or insufficient sterility during sample handling.
Particles in these cases often times are fibrous (cellulose-based),
polymers or glass particles resulting from delamination. The
Raman spectrum of cellulose is shown in Fig. 3 (trace e). One
characteristic is the presence of a doublet at 1096 and
1123 cm−1 arising from a combination of ν(C-C) and ν(C-O)
stretch vibrations (21). Most features in the spectrum are
broadened, in particular bands between 1200 and
1400 cm−1 arising from δ(HCC), δ(HCO) and δ(HOC) bend-
ing vibrations. Polymer compounds are easily identified be-
cause their vibrational spectra are composed of highly re-
solved bands due to their higher order structure and orga-
nized environment. As an example we show the Raman
spectrum of polypropylene which can be introduced into the
sample e.g., by storage containers or pipette tips. The strong
transitions at 809 and 842 cm−1 can be assigned to δ(CH2)
rocking vibrations (30). Other strong transitions arise at
1153 cm−1 (combination of ν(C-C) stretch and δ(CH2) bend-
ing), 1168 cm−1 (ν(C-C) stretch, δ(CH2) rocking and δ(CH2)
wagging), and 1460 cm−1 (δ(CH2) bending) (30).
Since molecular identity is associated with a characteristic
vibrational fingerprint, it can be seen that both highly diverse
and very similar molecules can be distinguished using Raman
spectroscopy. Most compounds can be identified unless they
are metal based and have only low-frequency vibrations below
the laser filter cutoff. In the next sections we focus on identifi-
cation of insoluble polysorbate 20 degradation products be-
cause this is particularly challenging due to the properties of
the particles, which are labile, temperature sensitive as well as
heterogeneous.
Identification of Degradation Products in Model
Systems
To study the feasibility of Raman spectroscopy to identify fatty
acid particles derived from polysorbate in complex mixtures,
we digested 0.2 mg/mL polysorbate 20 with 30 ppm rabbit
liver esterase at 40°C for 12 h. Esterases hydrolyse esters into
fatty acids and alcohols. Polysorbate 20 contains a complex
mixture of fatty acid side-chains with the predominant species
lauric acid and myristic acid in a ~3.5:1 ratio (12). Therefore,
most of the particles generated from enzymatic treatment of
polysorbate 20 are expected to be composed of mixtures of
these fatty acids, in particular of lauric acid and myristic acid.
The spectra for several particles highlighting the range be-
tween 1000 and 1200 cm−1 are shown in Fig. 4A. The spectra
showing the entire spectral range can be found in Fig. S6. It
can be seen that the two strong bands arising from ν(C-C)
stretches at 1065 and 1126 cm−1 are the same in all particles
and do not allow for discrimination of different fatty acids.
However, the marker band of the unique ν(C-C) stretch locat-
ed between those two bands shows heterogeneity with main
peaks at both 1085 and 1093 cm−1 in agreement with the
unique ν(C-C) stretch vibrations found in lauric and myristic
acid. No band at 1175 cm−1 is present indicating either the
absence of capric acid or the possibility that most of the capric
acid is still solubilized and not a constituent of the particles.
Some particles show a small shoulder around 1100 cm−1 sug-
gesting the presence of small amounts of palmitic acid. The
ratio between lauric and myristic acid is ~1:1. Based on the
relative abundance of lauric and myristic acid in polysorbate
20 as describend above (3.5:1 ratio between lauric andmyristic
acid) this can be interpreted in terms of their different solubility
(short chain fatty acids have a higher solubility). So even
though there will be more lauric acid side chains in the poly-
sorbate 20 raw material it is likely that a larger fraction of it is
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solubilized and that the actual insoluble particles have larger
contributions of the longer chain fatty acids. In conclusion,
most insoluble particles on the filter are mixtures of lauric acid,
myristic acid, and possibly small amounts of palmitic acid.
In a second model system, 0.2 mg/mL polysorbate 20 was
digested with 30 ppm pancreatic lipase at 40°C for 12 h.
Lipases convert triglyceride substrates to monoglycerides and
fatty acids (31). When drying particles in a desiccator over
phosphorous pentoxide in a manner similar to the previous
experiment, it was discovered that most of the particles disap-
peared during the drying process. So far there is no obvious
explanation for this but it might be due to the fact that the
melting point of these particles was much lower than in the
previous case. Therefore, we filtered particles and transferred
the filter directly to the cold cryo-cell without any drying. The
Raman spectra are shown in Fig. 4B and it can be seen that
they are very similar to the spectra in the other model system.
Most particles mainly consist of lauric acid and myristic acid
with small contributions of palmitic acid.
To summarize, chemical identities of similar components
in heterogeneous particles can be captured using Raman spec-
troscopy. If signal-to-nose is good enough it is even possible to
estimate relative contributions of each fatty acid to the indi-
vidual particles as stated above (~1:1 ratio between lauric and
myristic acid).
Identification of Degradation Products in Aged
Antibody Formulations
After evaluating known model systems, we tested our method-
ology on aged antibody formulations containing particles of
unknown identity. Two formulations were chosen that were
aged at 5°C for 4 years (Mab1) and at 5°C for 6 years (Mab2).
Polysorbate 20 quantification using HPLC assay with ELSD
detection showed that 70% of all polysorbate 20 in Mab1
formulation and 42% in Mab2 formulation were intact (see
Fig. S4). Although, protein particles were observed in these
formulations (Fig. S5), we focus this discussion on polysor-
bate–related degradation products as the protein particles
are readily distinguishable from fatty acids and fatty acid esters
based on the features described in a previous section, i.e., the
amide bands and a strong phenylalanine band around
1000 cm−1.
In the first experiment, a filter containing particles from
Mab1 formulation was transferred directly to the cold cryo-
cell and spectra were acquired of two particles (particle 1 and
particle 2). In a second experiment, the filter was dried over
phosphorous pentoxide for 2 h before transferring it to the
cryo-cell, and data was acquired (particles 3–5) for compari-
son against the non-dried sample. Similar to the results ob-
tained from the model systems, it can be seen that the that the
two strong bands arising from ν(C-C) stretches at 1065 and
1126 cm−1 are similar in each particle and do not allow for
discrimination (full range spectra are shown in Fig. S7). The
marker band in between these strong bands shows heteroge-
neity as well. However, when compared with the model sys-
tems, the particles in the Mab formulation are primarily com-
posed of the longer chain fatty acids palmitic and myristic acid
rather than lauric and myristic acids as observed in the model
systems. The characteristic band at 1158 cm−1 arising from
the unique ν(C-C) stretch vibration in ethylene glycol
monolaurate is missing. The presence of the characteristic
Fig. 4 Experimental Raman
spectra of fatty acid particles in
model systems of polysorbate 20
digested with (a) rabbit liver
esterase and (b) pancreatic lipase.
Experimental conditions:
T=233 K, 16 mW laser power,
300 s accumulation time. For
comparison the reference spectra of
capric, lauric, myristic and palmitic
acid are shown.
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doublet of the δ(CH2) rocking modes in the full range spectra
further confirms that the particles are fatty acids rather than
fatty acid esters (Fig. S7). In conclusion, there was no differ-
ence in particle identity between dried sample and sample
containing residual water indicating that the drying process
did not change particle composition.
Particles fromMab2 formulation were dried over phospho-
rous pentoxide for 2 h before measurement. The spectra are
similar to the ones obtained from particles in Mab1 formula-
tion (Fig. 5b). The chemical identity of the particles is com-
prised mainly of palmitic and myristic acid. In a control ex-
periment, particles from Mab2 formulation were dried over-
night over phosphorus pentoxide. After drying, partial recov-
ery of the low-frequency vibration at 376 cm−1 was observed
consistent with the presence of palmitic acid, which showed
similar behavior (Fig. S8). No further recovery was achieved
by longer drying times. Unfortunately, drying under these
conditions leads to loss of short chain fatty acids due to their
higher volatility. Therefore, we do not recommend prolonged
drying of particles. To recover spectra identical to the library
spectra shown in Fig. 1, it may be necessary to perform a
temperature jump and recrystallize the fatty acids back to
their original crystal structure.
In general, these experiments demonstrate that identifica-
tion of different components in mixtures of particles in the size
range 10–80 μm is possible based on the presence of unique
spectral features. Since molecules in particles may be
amorphous and experience a different microenviron-
ment than in its original dry structure, careful control
experiments coupled with DFT calculations should be
included to assure that these changes in vibrational spectra
are captured by the operator.
Implications for the Mechanism of Degradation
As mentioned previously, the mechanism of polysorbate deg-
radation in protein formulations is still under debate. It is
believed that hydrolysis is one of the major mechanisms at
low temperature while oxidation is accelerated by stress con-
ditions such as elevated temperature or prolonged light expo-
sure, but there is no conclusive evidence yet (12). Since both
pathways create different degradation products the chemical
nature of the insoluble particles can help reveal the mecha-
nism of degradation.
We investigated insoluble particles in two different Mab
formulations stored at low temperature for extended period.
Raman spectroscopy confirmed that the particles consist of
fatty acids rather than fatty acid esters. In addition, particles
are comprised of mixtures of the long chain fatty acids
palmitic andmyristic acid and not of the short chain fatty acids
lauric and capric acid. This can be explained based on
the much lower solubility of the longer chain fatty acids,
which preferentially precipitate out in solution while the
short chain fatty acids might be still solubilized. There
was no evidence for the presence of insoluble particles
comprised of fatty acid esters (note that fatty acid esters
can still be present in solubilized form). Therefore, our
findings indicate that hydrolysis is the predominant
mechanism leading to particle formation under these
experimental conditions.
Fig. 5 Experimental Raman
spectra of isolated particles from
Mab1 and Mab2 formulations. For
comparison the reference spectra of
capric, lauric, myristic, palmitic acid
and ethylene glycol monolaurate
(EGM) are shown. Experimental
conditions: (a) T=233 K, 16 mW
laser power, 300 s accumulation
time. Particle 1 and 2 were
transferred directly to the cold
Raman cell. Particles 3–5 were
dried over phosphorous pentoxide
for 2 h before measurement (b)
T=−40°C, 4 mW laser power,
90 s accumulation time. Particles
were dried over phosphorous
pentoxide for 2 h before
measurement.
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CONCLUSION
Surfactant degradation in biopharmaceutical formulations is
one of the processes that can contribute to insoluble particu-
late formation because hydrophobic degradation products of
surfactant usually have low solubility in formulation buffer.
Polysorbate 20 can degrade via hydrolysis or oxidative dam-
age resulting in different degradation products and particulate
matter. Information about the chemical identity of the
resulting particles enables elucidation of the major degrada-
tion pathway leading to particle formation and may aid in
prevention of these processes.
In the present study, we exploited the potential of disper-
sive Raman spectroscopy for identification of degradation
products of polysorbate 20. Raman spectroscopy is well suited
for studying biological systems because water shows only very
weak Raman activity. Its biggest drawbacks include back-
ground fluorescence due to impurities in the formulations,
which can be minimized by using 785 nm excitation, as well
as the possibility of laser-induced photodamage of the sample.
In general, insoluble particles resulting form polysorbate 20
degradation are fatty acids or fatty acid esters, all of which are
highly similar molecules. However, since each molecule is
slightly different, it exhibits unique vibrational fingerprints
allowing for discrimination. We performed Raman spectros-
copy on purified fatty acids to identify these unique vibrations
and evaluated different hydration states to ensure positive
identity. Analysis was made quantitative by comparing exper-
imental spectra with calculated spectra using DFT in which it
was possible to identify the unique vibrations as well. Model
systems with known composition of degradation products
demonstrated that it is possible to disentangle mixtures of fatty
acids using Raman spectroscopy. Finally, fatty acids were
identified as the main type of particles in two different anti-
body formulations, which were aged at 5°C for several years.
These particles were mainly composed of the long chain fatty
acids myristic and palmitic acid, whereas the particles in the
model systems were mainly composed of lauric and capric
acid. This indicates that under these conditions, polysorbate
hydrolysis is the predominant mechanism for particle
formation.
In conclusion, Raman spectroscopy is a powerful tool to
identify particles in protein formulations. Its advantage com-
pared to FTIR spectroscopy is based on the fact that there is
no interference by water and use of high power lasers enables
identification of much smaller particles (down to 0.5 μm de-
pending on the optical properties of the particle). One draw-
back, however, is absolute quantification of each fatty acid
component in the particles due to the very high similarity of
the vibrational spectra and since the Raman process itself is
not based on absorption of light but on scattering.
Further studies are ongoing and focus on different product-
related particles to identify reasons for instability of excipients.
Especially challenging is particle identification in fairly stable
formulations because of the limited number and small size of
particles present. In these cases, Raman spectroscopy is the
method of choice for chemical identification due to its higher
sensitivity compared to FTIR spectroscopy. Knowledge of
degradation pathways enables the manufacturer to avoid
them and improve overall product quality and safety.
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